Weekly Update: New diabetes clinical trial (15 items)

New diabetes clinical trial: Using 32 - Gauge Needles With Lengths of 5 mm and 8 mm on Pain Post-injection, Leak and Blood Glucose Published on: July 07, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Device: 5-mm 32-gauge Insulin needles in the first three days of Intervention;   Device: 8-mm 32-gauge Insulin needles in the first three days of Intervention;   Device: 5-mm 32-gauge Insulin needles in the last three days of Intervention;   Device: 8-mm 32-gauge Insulin needles in the last three days of Intervention Sponsor:   Baqiyatallah Medical Sciences University Recruiting https://clinicaltrials.gov/ct2/show/NCT04460092?term=diabetes&sfpd_d=14 July 07, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Cognitive Behavioral Sleep Intervention for Prevention of Type 2 Diabetes Published on: July 03, 2020 at 07:00PM Conditions:   PreDiabetes;   Insomnia;   Sleep Deprivation Interventions:   Behavioral: Intensive Lifestyle Intervention;   Behavioral: Intensive Lifestyle Intervention enhanced with Cognitive Behavioral Sleep Intervention Sponsor:   The University of Hong Kong Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04457440?term=diabetes&sfpd_d=14 July 07, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Infrared Socks Effect on Oxygenation of Diabetics Feet and Lower Leg Published on: July 07, 2020 at 07:00PM Condition:   Diabete Mellitus Intervention:   Device: Active IR sock Sponsors:   Yale University;   CIRCULATE, Inc. Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04460612?term=diabetes&sfpd_d=14 July 07, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus Published on: July 07, 2020 at 07:00PM Condition:   Type 2 Diabetes Treated With Insulin Interventions:   Drug: Insulin glargine;   Drug: NovoLog;   Drug: Insulin Fiasp;   Other: Standard carbohydrate diet Sponsors:   Boston Medical Center;   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04460326?term=diabetes&sfpd_d=14 July 07, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Empagliflozin and Cardiac Remodelling in People Without Diabetes Published on: July 08, 2020 at 07:00PM Conditions:   Cardiovascular Diseases;   Left Ventricular Hypertrophy Interventions:   Drug: Empagliflozin;   Drug: Placebo Sponsors:   St. Michael's Hospital, Toronto;   Canadian Medical and Surgical Knowledge Translation Research Group;   Boehringer Ingelheim;   Applied Health Research Centre Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04461041?term=diabetes&sfpd_d=14 July 08, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes Patients Published on: July 08, 2020 at 07:00PM Condition:   Nonalcoholic Steatohepatitis Intervention:   Sponsor:   University of California, San Diego Completed https://clinicaltrials.gov/ct2/show/NCT04462081?term=diabetes&sfpd_d=14 July 08, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: INTEGRATE-D: A Pilot Test to Support Integration of Medical and Psychosocial Care for People With Type II Diabetes Published on: July 08, 2020 at 07:00PM Conditions:   Type II Diabetes;   Primary Health Care;   Behavioral Health Intervention:   Behavioral: INTEGRATE-D Sponsor:   Oregon Health and Science University Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04461405?term=diabetes&sfpd_d=14 July 08, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before Published on: July 08, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Insulin icodec;   Drug: Insulin glargine Sponsor:   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04460885?term=diabetes&sfpd_d=14 July 08, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Isoleucine Intake and Intermediary Metabolism in Type 2 Diabetes Published on: July 08, 2020 at 07:00PM Condition:   Type 2 Diabetes Interventions:   Dietary Supplement: Oral Supplement;   Dietary Supplement: Placebo Sponsor:   Texas A&M University Recruiting https://clinicaltrials.gov/ct2/show/NCT04461236?term=diabetes&sfpd_d=14 July 08, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: FreeStyle Libre 3 Continuous Glucose Monitoring System Accuracy Study Published on: July 09, 2020 at 07:00PM Condition:   Diabetes Mellitus Intervention:   Device: FreeStyle Libre 3 Sponsor:   Abbott Diabetes Care Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04464772?term=diabetes&sfpd_d=14 July 09, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: A Comparison Between the Effects of Conventional Diets vs Intermittent Fasting Diabetic and Pre-diabetic Patients Published on: July 09, 2020 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   PreDiabetes Interventions:   Behavioral: Calorie Restriction;   Behavioral: Time Restricted Feeding;   Behavioral: Time Restricted Feeding with Calorie Restriction Sponsors:   Usman Bin Hameed;   World Health Organization Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04463277?term=diabetes&sfpd_d=14 July 09, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: Study of the Factors Favoring the Transition From Prediabetes to Diabetes on Reunion Island. Published on: July 09, 2020 at 07:00PM Condition:   Diabetes Intervention:   Other: prevention program for prediabetes "Say No to Diabetes" Sponsor:   Centre Hospitalier Universitaire de la Réunion Recruiting https://clinicaltrials.gov/ct2/show/NCT04463160?term=diabetes&sfpd_d=14 July 09, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM Published on: July 10, 2020 at 07:00PM Condition:   Type 2 Diabetes Interventions:   Drug: IBI362;   Drug: Placebo;   Drug: Dulaglutide Sponsor:   Innovent Biologics (Suzhou) Co. Ltd. Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04466904?term=diabetes&sfpd_d=14 July 10, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes Published on: July 10, 2020 at 07:00PM Conditions:   Healthy;   Type 2 Diabetes Interventions:   Biological: Saline;   Biological: Exendin-9,39;   Biological: Saline + Intralipid/Heparin;   Biological: Exendin-9,39 + Intralipid/Heparin Sponsors:   Adrian Vella;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04466618?term=diabetes&sfpd_d=14 July 10, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 Diabetes Published on: July 10, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: JTT-662;   Drug: Placebo Sponsor:   Akros Pharma Inc. Recruiting https://clinicaltrials.gov/ct2/show/NCT04465877?term=diabetes&sfpd_d=14 July 10, 2020 at 02:24PM via ClinicalTrials.gov